TGTX
TG Therapeutics Inc.
Company Overview
| Mkt Cap | $5.14B | Price | $34.78 |
| Volume | 3.26M | Change | +2.23% |
| P/E Ratio | 219.6 | Open | $34.01 |
| Revenue | $329.0M | Prev Close | $34.02 |
| Net Income | $23.4M | 52W Range | $22.92 - $46.48 |
| Div Yield | N/A | Target | $43.57 |
| Overall | 55 | Value | 20 |
| Quality | 55 | Technical | 90 |
No chart data available
Stock Overview
Updated DailyTG Therapeutics Inc. (TGTX) is a leading Healthcare company in the Biotechnology industry, currently trading at $34.78 with a market capitalization of $5.14 billion. The stock is trading in the middle of its 52-week range, demonstrating average quality indicators with a MarketXLS quality score of 55.
Today's trading session shows TGTX with a volume of 3.26 million shares. The stock opened down 0.03% from yesterday's close of $34.02. Current analyst estimates project earnings of $0.75 per share for this year, with next year targeting $1.79.
TGTX demonstrates very strong technical momentum based on technical analysis. The company trades on the NSC exchange and operates alongside industry peers including RDY, INFI, ALKS, GNCA.
Key investment considerations for TGTX include average overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 25.3%. The stock shows expensive valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 07:17 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TGTX | $34.78 | +2.2% | 3.26M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |